Cipla Ltd offers to take over Cipla Medpro South Africa. Two Ciplas from two continents would merge into one. Indian pharmaceutical company Cipla Ltd increased its offer by 17% to fully acquire South African drug company Cipla Medpro South Africa Ltd.

Ryanair's third attempt to purchase Aer Lingus refused by EU regulators. European Union regulators have refused to validate the third purchase attempt by Ryanair to acquire Aer Lingus.

French water utility Veolia is now considering to buy out some minority investors but will not make acquisitions policy.

Mylan increases market share with Stride purchase. The world's second largest stand alone generic drugs maker, Mylan Inc has agreed to purchase Stride Acroblab Ltd's injectable medicine unit.

BCBG sale may reach US$1 billion BCBG Max Azria Group Inc, the fashion house to stars such as Beyonce and Angelina Jolie, is now expecting to sell at an amount nearing US$1 billion.

Y&R, the wholly-operating company owned by WPP PLC, has acquired a majority stake of Turkish C-Section.

Mediwatch and Genesis Medical have agree to dissolve their joint venture after they did not agree on several commercial aspects during their negotiations.

Allianz has been in the focus of its own growth in the German market. The business unit of Allianz in Germany has been considering merger opportunities in the Germany market as it focuses on increasing its business presence, according to Markus Riess, unit head.

Sorin Group and Enopace Biomedical have reached agreement in which the former is provided with the power to acquire the latter in the future.

Bayer AG is predicting that its Xarelto, a drug to prevent stroke, will reach peak annual sales. Bayer AG said it expects Xarelto, its new promising drug for treating and preventing stroke, to reach peak annual sales at the end of the decade, company's chief executive Marijin Dekker said in a statement.